Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
Kristin N. Varhaug, Øivind Torkildsen, Kjell‐Morten Myhr, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 166

Showing 1-25 of 166 citing articles:

Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
Emma L. van der Ende, Lieke Meeter, Jackie M. Poos, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 12, pp. 1103-1111
Open Access | Times Cited: 158
Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management
Mark S. Freedman, Sharmilee Gnanapavan, Ronald A. Booth, et al.
EBioMedicine (2024) Vol. 101, pp. 104970-104970
Open Access | Times Cited: 57
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
Julia Åkesson, Sara Hojjati, Sandra Hellberg, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1
Jessica Shipley, James Beharry, Wei Zhen Yeh, et al.
The Medical Journal of Australia (2025)
Closed Access | Times Cited: 2
Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies
Wolfgang Singer, Ann M. Schmeichel, Mohammad Shahnawaz, et al.
Annals of Neurology (2020) Vol. 88, Iss. 3, pp. 503-512
Open Access | Times Cited: 104
The Evolution of Neurofilament Light Chain in Multiple Sclerosis
Carolina Ferreira‐Atuesta, Saúl Reyes, Gavin Giovanonni, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 101
Blood biomarkers for mild traumatic brain injury: a selective review of unresolved issues
Daniel B. Hier, Tayo Obafemi-Ajayi, Matthew S. Thimgan, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 93
Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson’s Disease: Roads to Biomarker Discovery
Anna Picca, Flora Guerra, Riccardo Calvani, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1508-1508
Open Access | Times Cited: 93
Chemical sensing platforms for detecting trace-level Alzheimer's core biomarkers
Kayoung Kim, Chang Heon Lee, Chan Beum Park
Chemical Society Reviews (2020) Vol. 49, Iss. 15, pp. 5446-5472
Closed Access | Times Cited: 79
Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure
Wolfgang Singer, Ann M. Schmeichel, Mohammad Shahnawaz, et al.
Annals of Neurology (2021) Vol. 89, Iss. 6, pp. 1212-1220
Open Access | Times Cited: 71
Neurofilament Light Chain Levels in Multiple Sclerosis Correlate With Lesions Containing Foamy Macrophages and With Acute Axonal Damage
Aletta M.R. van den Bosch, Nina L. Fransen, Matthew R. J. Mason, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 3
Open Access | Times Cited: 41
Blood-based biomarkers for Alzheimer’s disease: a multicenter-based cross-sectional and longitudinal study in China
Feng Gao, Linbin Dai, Qiong Wang, et al.
Science Bulletin (2023) Vol. 68, Iss. 16, pp. 1800-1808
Open Access | Times Cited: 24
Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy
Panoraia Baka, Livia Steenken, Fabiola Escolano‐Lozano, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 4
Open Access | Times Cited: 13
Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity
Alexandra E. Oppong, Leda Coelewij, G S M Robertson, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109225-109225
Open Access | Times Cited: 10
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis
Tanuja Chitnis, Ferhan Qureshi, Victor M. Gehman, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Effects of Physical Exercise on Neurofilament Light Chain and Glial Fibrillary Acidic Protein Level in Patients with Multiple Sclerosis: A Systematic Review and Bayesian Network Meta-Analysis
Aitor Blázquez-Fernández, Víctor Navarro‐López, Selena Marcos-Antón, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 839-839
Open Access | Times Cited: 1
Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy
Isabelle Weinhofer, Paulus Rommer, Bettina Zierfuss, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 44
A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease
Melissa M. Budelier, Yingxin He, Nicolas R. Barthélemy, et al.
Brain Communications (2022) Vol. 4, Iss. 2
Open Access | Times Cited: 36
Maximizing treatment efficacy through patient stratification in neuropathic pain trials
Ralf Baron, Anthony H. Dickenson, Margarita Calvo, et al.
Nature Reviews Neurology (2022) Vol. 19, Iss. 1, pp. 53-64
Closed Access | Times Cited: 36
Autoantibodies against central nervous system antigens in a subset of B cell–dominant multiple sclerosis patients
Stefanie Küerten, Tobias V. Lanz, Nithya Lingampalli, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 35, pp. 21512-21518
Open Access | Times Cited: 50
Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis
Maija Saraste, Svetlana Bezukladova, Markus Matilainen, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 50, pp. 102810-102810
Closed Access | Times Cited: 40
Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy—Kynurenines Are Important Players
Dániel Sandi, Zsanett Fricska‐Nagy, Krisztina Bencsik, et al.
Molecules (2021) Vol. 26, Iss. 11, pp. 3423-3423
Open Access | Times Cited: 40
Multiple Sclerosis Biomarker Discoveries by Proteomics and Metabolomics Approaches
Ameneh Jafari, Amirhesam Babajani, Mostafa Rezaei‐Tavirani
Biomarker Insights (2021) Vol. 16
Open Access | Times Cited: 36
The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use
Dafni Birmpili, Imane Charmarke Askar, Kévin Bigaut, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11532-11532
Open Access | Times Cited: 24
The role of systemic ımmune ınflammatory ındex in showing active lesion ın patients with multiple sclerosis
Şeyda Figül Gökçe, Asli Bolayır, Burhanettin Çiğdem, et al.
BMC Neurology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top